• This record comes from PubMed

Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

. 2024 Oct ; 23 (10) : 973-1003.

Language English Country Great Britain, England Media print

Document type Journal Article

Links

PubMed 39304265
PubMed Central PMC12254192
DOI 10.1016/s1474-4422(24)00369-7
PII: S1474-4422(24)00369-7
Knihovny.cz E-resources

BACKGROUND: Up-to-date estimates of stroke burden and attributable risks and their trends at global, regional, and national levels are essential for evidence-based health care, prevention, and resource allocation planning. We aimed to provide such estimates for the period 1990-2021. METHODS: We estimated incidence, prevalence, death, and disability-adjusted life-year (DALY) counts and age-standardised rates per 100 000 people per year for overall stroke, ischaemic stroke, intracerebral haemorrhage, and subarachnoid haemorrhage, for 204 countries and territories from 1990 to 2021. We also calculated burden of stroke attributable to 23 risk factors and six risk clusters (air pollution, tobacco smoking, behavioural, dietary, environmental, and metabolic risks) at the global and regional levels (21 GBD regions and Socio-demographic Index [SDI] quintiles), using the standard GBD methodology. 95% uncertainty intervals (UIs) for each individual future estimate were derived from the 2·5th and 97·5th percentiles of distributions generated from propagating 500 draws through the multistage computational pipeline. FINDINGS: In 2021, stroke was the third most common GBD level 3 cause of death (7·3 million [95% UI 6·6-7·8] deaths; 10·7% [9·8-11·3] of all deaths) after ischaemic heart disease and COVID-19, and the fourth most common cause of DALYs (160·5 million [147·8-171·6] DALYs; 5·6% [5·0-6·1] of all DALYs). In 2021, there were 93·8 million (89·0-99·3) prevalent and 11·9 million (10·7-13·2) incident strokes. We found disparities in stroke burden and risk factors by GBD region, country or territory, and SDI, as well as a stagnation in the reduction of incidence from 2015 onwards, and even some increases in the stroke incidence, death, prevalence, and DALY rates in southeast Asia, east Asia, and Oceania, countries with lower SDI, and people younger than 70 years. Globally, ischaemic stroke constituted 65·3% (62·4-67·7), intracerebral haemorrhage constituted 28·8% (28·3-28·8), and subarachnoid haemorrhage constituted 5·8% (5·7-6·0) of incident strokes. There were substantial increases in DALYs attributable to high BMI (88·2% [53·4-117·7]), high ambient temperature (72·4% [51·1 to 179·5]), high fasting plasma glucose (32·1% [26·7-38·1]), diet high in sugar-sweetened beverages (23·4% [12·7-35·7]), low physical activity (11·3% [1·8-34·9]), high systolic blood pressure (6·7% [2·5-11·6]), lead exposure (6·5% [4·5-11·2]), and diet low in omega-6 polyunsaturated fatty acids (5·3% [0·5-10·5]). INTERPRETATION: Stroke burden has increased from 1990 to 2021, and the contribution of several risk factors has also increased. Effective, accessible, and affordable measures to improve stroke surveillance, prevention (with the emphasis on blood pressure, lifestyle, and environmental factors), acute care, and rehabilitation need to be urgently implemented across all countries to reduce stroke burden. FUNDING: Bill & Melinda Gates Foundation.

See more in PubMed

Roth GA, Mensah GA, Johnson CO, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982–3021. PubMed PMC

Vaughan AS, Ritchey MD, Hannan J, Kramer MR, Casper M. Widespread recent increases in county-level heart disease mortality across age groups. Ann Epidemiol. 2017;27:796–800. PubMed PMC

Scott CA, Li L, Rothwell PM. Diverging temporal trends in stroke incidence in younger vs older people: a systematic review and meta-analysis. JAMA Neurol. 2022;79:1036–1048. PubMed PMC

Wright JS, Wall HK, Ritchey MD. Million Hearts 2022: small steps are needed for cardiovascular disease prevention. JAMA. 2018;320:1857–1858. PubMed PMC

GBD 2019 Stroke Collaborators Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820. PubMed PMC

Feigin VL, Owolabi MO, Feigin VL, et al. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission. Lancet Neurol. 2023;22:1160–1206. PubMed PMC

Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10 PubMed PMC

GBD 2019 Risk Factors Collaborators Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223–1249. PubMed PMC

GBD 2021 Risk Factors Collaborators Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2162–2203. PubMed PMC

GBD 2021 Diseases and Injuries Collaborators Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133–2161. PubMed PMC

Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58:113–130. PubMed PMC

GBD 2016 Causes of Death Collaborators Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–1210. PubMed PMC

GBD 2016 Stroke Collaborators Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439–458. PubMed PMC

Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392:2052–2090. PubMed PMC

Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016;15:913–924. PubMed

Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448–457. PubMed

Prust ML, Forman R, Ovbiagele B. Addressing disparities in the global epidemiology of stroke. Nat Rev Neurol. 2024;20:207–221. PubMed

An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017;19:3–10. PubMed PMC

Wang S, Zou XL, Wu LX, et al. Epidemiology of intracerebral hemorrhage: a systematic review and meta-analysis. Front Neurol. 2022;13 PubMed PMC

Nissinen A, Bothig S, Granroth H, Lopez AD. Hypertension in developing countries. World Health Stat Q. 1988;41:141–154. PubMed

Dai X, Gakidou E, Lopez AD. Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action. Tob Control. 2022;31:129–137. PubMed

Sun J, Qiao Y, Zhao M, Magnussen CG, Xi B. Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: a systematic analysis of Global Burden of Disease Study 2019. BMC Med. 2023;21:222. PubMed PMC

De Venecia T, Lu M, Figueredo VM. Hypertension in young adults. Postgrad Med. 2016;128:201–207. PubMed

Haseler E, Sinha MD. Hypertension in children and young adults. Pediatr Clin North Am. 2022;69:1165–1180. PubMed

Shin D, Choi J, Lee H-Y. Suboptimal control status of young hypertensive population. Clin Hypertens. 2023;29:13. PubMed PMC

Poobalan A, Aucott L. Obesity among young adults in developing countries: a systematic overview. Curr Obes Rep. 2016;5:2–13. PubMed PMC

de Onis M, Blössner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92:1257–1264. PubMed

Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390:2627–2642. PubMed PMC

GBD 2021 Diabetes Collaborators Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203–234. PubMed PMC

Roseleur J, Gonzalez-Chica DA, Karnon J, Stocks NP. Predicted cardiovascular disease risk and prescribing of antihypertensive therapy among patients with hypertension in Australia using MedicineInsight. J Hum Hypertens. 2023;37:370–378. PubMed PMC

Mortensen MB, Tybjærg-Hansen A, Nordestgaard BG. Statin eligibility for primary prevention of cardiovascular disease according to 2021 European Prevention Guidelines compared with other international guidelines. JAMA Cardiol. 2022;7:836–843. PubMed PMC

Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005;365:434–441. PubMed

Van Dusen RA, Abernethy K, Chaudhary N, Paudyal V, Kurmi O. Association of the COVID-19 pandemic on stroke admissions and treatment globally: a systematic review. BMJ Open. 2023;13 PubMed PMC

Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372:1333–1341. PubMed PMC

Feigin VL, Brainin M, Norrving B, et al. What is the best mix of population-wide and high-risk targeted strategies of primary stroke and cardiovascular disease prevention? J Am Heart Assoc. 2020;9 PubMed PMC

Feigin VL, Martins SC, Brainin M, et al. Hankey Graeme J. Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention: a systematic scoping review. Eur J Neurol. 2024;31 PubMed PMC

Owolabi MO, Thrift AG, Martins S, et al. The state of stroke services across the globe: report of World Stroke Organization–World Health Organization surveys. Int J Stroke. 2021;16:889–901. PubMed PMC

Feigin VL, Owolabi MO, World Stroke Organization–Lancet Neurology Commission Stroke Collaboration Group Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission. Lancet Neurol. 2023;22:1160–1206. PubMed PMC

Hwang J, Yi H, Jang M, et al. Air pollution and subarachnoid hemorrhage mortality: a stronger association in women than in men. J Stroke. 2022;24:429–432. PubMed PMC

Yorifuji T, Kawachi I, Sakamoto T, Doi H. Associations of outdoor air pollution with hemorrhagic stroke mortality. J Occup Environ Med. 2011;53:124–126. PubMed

Xu R, Wang Q, Wei J, et al. Association of short-term exposure to ambient air pollution with mortality from ischemic and hemorrhagic stroke. Eur J Neurol. 2022;29:1994–2005. PubMed

Institute for Health Metrics and Evaluation GBD 2021 Compare Data Visualization. https://collab2021.healthdata.org/gbd-compare/

Vineis P, Chan Q, Khan A. Climate change impacts on water salinity and health. J Epidemiol Glob Health. 2011;1:5–10. PubMed PMC

Ranta A, Kang J, Saad A, et al. Climate change and stroke: a topical narrative review. Stroke. 2024;55:1118–1128. PubMed

Anenberg SC, Haines S, Wang E, Nassikas N, Kinney PL. Synergistic health effects of air pollution, temperature, and pollen exposure: a systematic review of epidemiological evidence. Environ Health. 2020;19:130. PubMed PMC

Lee BJ, Kim B, Lee K. Air pollution exposure and cardiovascular disease. Toxicol Res. 2014;30:71–75. PubMed PMC

WHO Climate change. Oct 12, 2023. https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health

WHO Climate change and noncommunicable diseases: connections. Nov 2, 2023. https://www.who.int/news/item/02-11-2023-climate-change-and-noncommunicable-diseases-connections

Feigin SV, Wiebers DO, Lueddeke G, et al. Proposed solutions to anthropogenic climate change: a systematic literature review and a new way forward. Heliyon. 2023;9 PubMed PMC

Koon AD, Marten R. Framing health taxes: a scoping review. BMJ Glob Health. 2023;8(suppl 8) PubMed PMC

Wright A, Smith KE, Hellowell M. Policy lessons from health taxes: a systematic review of empirical studies. BMC Public Health. 2017;17:583. PubMed PMC

Blakely T, Cleghorn C, Mizdrak A, et al. The effect of food taxes and subsidies on population health and health costs: a modelling study. Lancet Public Health. 2020;5:e404–e413. PubMed

GBD 2019 Diseases and Injuries Collaborators Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...